Original Research
Published on 06 Nov 2025
In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1673056
- 2,398 views
Type at least 3 characters
1,096 articles
articles
Original Research
Published on 06 Nov 2025
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1692250
- 1,091 views
Clinical Trial
Published on 05 Nov 2025
Combination of remazolam and alfentanil on hemodynamics, postoperative cognitive function, and adverse cardiovascular events in elderly patients undergoing laparoscopic cholecystectomy: a randomized controlled trial
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1653593
- 1,288 views
Original Research
Published on 05 Nov 2025
Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1637441
- 1,125 views
Original Research
Published on 03 Nov 2025
Impact of the Warburg effect on nucleotide homeostasis in human retinal endothelial cells and its relevance to proliferative diabetic retinopathy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660067
- 2,569 views
Original Research
Published on 31 Oct 2025
Net health benefit of mavacamten for the treatment of Chinese patients with obstructive hypertrophic cardiomyopathy: a model-based economic evaluation
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636732
- 1,629 views
Original Research
Published on 24 Oct 2025
Cholestane-3β,5α,6β-triol induces cancer cell death by activating GSDME-mediated pyroptosis
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1667156
- 1,495 views
Original Research
Published on 23 Oct 2025
Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1676770
- 1,226 views
Original Research
Published on 21 Oct 2025
Effectiveness and safety of esketamine in laparoscopic surgery patients: a systematic review and meta-analysis of randomized controlled trials
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1663348
- 1,896 views
Correction
Published on 20 Oct 2025
Correction: Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1721652
- 1,023 views
Mini Review
Published on 15 Oct 2025
Mini review: Persister cell control strategies
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1706115
- 3,481 views
Mini Review
Published on 14 Oct 2025
Faricimab for retinal vein occlusion: a review of current evidence and future perspectives
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646806
- 3,882 views
Original Research
Published on 13 Oct 2025
Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1661939
- 1,988 views
- 1 citation
Original Research
Published on 10 Oct 2025
Modelling of clinical TQT studies outcomes from preclinical cardiovascular safety pharmacology studies using the one-step QTc model
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619547
- 2,120 views
- 1 citation
Original Research
Published on 09 Oct 2025
Targeting macrophage-myofibroblast transition with Caulis spatholobi to attenuate renal interstitial fibrosis: integrated UHPLC-Q-Exactive Orbitrap-MS, network pharmacology, and experimental validation
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649902
- 2,027 views
Original Research
Published on 09 Oct 2025
Remifentanil reduces post-induction hypotension compared to fentanyl in thoracoscopic esophagectomy: a retrospective cohort study
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660228
- 2,121 views
Review
Published on 08 Oct 2025
Research progress on DNA hydroxymethylation in atrial fibrillation: a review
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591675
- 2,015 views
Original Research
Published on 07 Oct 2025
Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1652957
- 2,415 views
Editorial
Published on 06 Oct 2025
Editorial: Modulation of ferroptosis via metabolic and signaling pathways: therapeutic opportunities across malignancies and degenerative diseases
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1712096
- 1,449 views
Case Report
Published on 01 Oct 2025
Losartan-associated toothache in a patient with diabetes and hypertension: a hypothesis-generating case report
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679182
- 3,230 views
- 1 citation
Review
Published on 30 Sep 2025
Effects of statins on sarcopenia with focus on mechanistic insights and future perspectives
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669591
- 5,265 views
- 1 citation
Perspective
Published on 29 Sep 2025
Animal-derived ingredients in medicines: a framework for ethical prescribing practices
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693059
- 1,859 views
Original Research
Published on 29 Sep 2025
Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1680875
- 2,582 views
Original Research
Published on 26 Sep 2025
Comparison of oliceridine and sufentanil in patient - controlled intravenous analgesia for post - thoracoscopic nausea and vomiting: a prospective, double - blind, randomized controlled trial
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1576154
- 2,983 views
- 1 citation